Essais liés3clinical trials
VilleLondonlocalisation
PaysUnited Kingdomlocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07714538

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
Cladribine (MAVENCLAD®) SEP Phase 2/3 NCT04695080 ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis ACTIVE_NOT_RECRUITING
BRAVE — Breath Research Narrow Validation for Gastrointestinal Cancer Detection Cancer À vérifier NCT07714538 BRAVE — Breath Research Narrow Validation for Gastrointestinal Cancer Detection RECRUITING
M5049 dose Myopathies Phase 2 NCT05650567 Study of M5049 in DM and PM Participants (NEPTUNIA) TERMINATED